Assignee
CHILDRENS MEDICAL CT CORP
US·98 granted patents·159 pending applications·569 citations·filing 2001–2025
Top patents by PatentIndex Score
257 records- 0198US11208683B2Methods of epigenetic analysisCHILDRENS MEDICAL CT CORP·Filed 2021·Granted Dec 28, 2021·14 cites·12 claims
- 0298US11072818B2Selective oxidation of 5-methylcytosine by TET-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2019·Granted Jul 27, 2021·14 cites·9 claims
- 0398US10767216B2Methods for distinguishing 5-hydroxymethylcytosine from 5-methylcytosineCHILDRENS MEDICAL CT CORP·Filed 2018·Granted Sep 8, 2020·15 cites·16 claims
- 0498US10731204B2Selective oxidation of 5-methylcytosine by TET-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Aug 4, 2020·15 cites·19 claims
- 0598US10041938B2Measuring a level of a 5-hydroxymethylcytosine in a sample from a subject having a cancer or suspected of having cancerCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Aug 7, 2018·17 cites·19 claims
- 0697US11826489B2Collagen scaffoldsCHILDRENS MEDICAL CT CORP·Filed 2021·Granted Nov 28, 2023·3 cites·14 claims
- 0797US10465234B2Selective oxidation of 5-methylcytosine by TET-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2018·Granted Nov 5, 2019·13 cites·11 claims
- 0897US10337053B2Labeling hydroxymethylated residuesCHILDRENS MEDICAL CT CORP·Filed 2018·Granted Jul 2, 2019·24 cites·7 claims
- 0997US10323269B2Selective oxidation of 5-methylcytosine by TET-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Jun 18, 2019·18 cites·15 claims
- 1097US10031131B2Selective oxidation of 5-methylcytosine by TET-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Jul 24, 2018·26 cites·10 claims
- 1196US12338489B2Selective oxidation of 5-methylcytosine by TET-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2024·Granted Jun 24, 2025·1 cites·26 claims
- 1296US12331346B2Selective oxidation of 5-methylcytosine by TET-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2024·Granted Jun 17, 2025·1 cites·26 claims
- 1396US12291742B2Selective oxidation of 5-methylcytosine by TET-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2024·Granted May 6, 2025·1 cites·30 claims
- 1496US12018320B2Selective oxidation of 5-methylcytosine by TET-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2022·Granted Jun 25, 2024·2 cites·13 claims
- 1596US10612076B2Selective oxidation of 5-methylcytosine by TET-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Apr 7, 2020·11 cites·17 claims
- 1696US10508301B2Detection of 5-hydroxymethylcytosine by glycosylationCHILDRENS MEDICAL CT CORP·Filed 2018·Granted Dec 17, 2019·11 cites·12 claims
- 1795US2025354202A1Methods of Epigenetic AnalysisCHILDRENS MEDICAL CT CORP·Filed 2024·Application pending·0 cites
- 1894US2025019747A1Selective oxidation of 5-methylcytosine by tet-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2024·Application pending·0 cites
- 1993US9228185B2Modulation of BCL11A for treatment of hemoglobinopathiesCHILDRENS MEDICAL CT CORP·Filed 2013·Granted Jan 5, 2016·13 cites·23 claims
- 2092US10662429B2Compositions and methods to treating hemoglobinopathiesCHILDRENS MEDICAL CT CORP·Filed 2019·Granted May 26, 2020·8 cites·17 claims
- 2192US6726715B2Fiber-reinforced heart valve prosthesisCHILDRENS MEDICAL CT CORP·Filed 2001·Granted Apr 27, 2004·304 cites·11 claims
- 2291US10273283B2Modified integrin polypeptides, modified integrin polypeptide dimers, and uses thereofCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Apr 30, 2019·7 cites·16 claims
- 2389US10980808B2Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathiesCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Apr 20, 2021·4 cites·9 claims
- 2489US2025333702A1Cells with increased immuno-regulatory properties and methods for their use and manufactureCHILDRENS MEDICAL CT CORP·Filed 2024·Application pending·0 cites
- 2588US11572543B2Targeting BCL11A enhancer functional regions for fetal hemoglobin reinductionCHILDRENS MEDICAL CT CORP·Filed 2016·Granted Feb 7, 2023·4 cites·7 claims
- 2688US11076846B2Methods and procedures for ligament repairCHILDRENS MEDICAL CT CORP·Filed 2019·Granted Aug 3, 2021·4 cites·6 claims
- 2788US2024091405A1Collagen scaffoldsCHILDRENS MEDICAL CT CORP·Filed 2023·Application pending·0 cites
- 2887US11076845B2Methods and procedures for ligament repairCHILDRENS MEDICAL CT CORP·Filed 2019·Granted Aug 3, 2021·3 cites·8 claims
- 2987US10266826B2Modulation of BCL11A for treatment of hemoglobinopathiesCHILDRENS MEDICAL CT CORP·Filed 2018·Granted Apr 23, 2019·4 cites·32 claims
- 3087US9968575B2Compounds for the treatment of obesity and methods of use thereofCHILDRENS MEDICAL CT CORP·Filed 2013·Granted May 15, 2018·6 cites·5 claims
- 3187US2025352695A1Collagen scaffoldsCHILDRENS MEDICAL CT CORP·Filed 2025·Application pending·0 cites
- 3287US2025101381A1Cells with increased immuno-regulatory properties and methods for their use and manufactureCHILDRENS MEDICAL CT CORP·Filed 2024·Application pending·0 cites
- 3386US11944625B2Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathiesCHILDRENS MEDICAL CT CORP·Filed 2021·Granted Apr 2, 2024·1 cites·17 claims
- 3486US9925161B2Compounds for the treatment of obesity and methods of use thereofCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Mar 27, 2018·3 cites·23 claims
- 3585US10314833B2Neosaxitoxin combination formulations for prolonged local anesthesiaCHILDRENS MEDICAL CT CORP·Filed 2014·Granted Jun 11, 2019·2 cites·17 claims
- 3684US11525119B2Immune cells derived from induced pluripotent stem cellCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Dec 13, 2022·5 cites·19 claims
- 3784US10786239B2Methods and procedures for ligament repairCHILDRENS MEDICAL CT CORP·Filed 2019·Granted Sep 29, 2020·2 cites·8 claims
- 3884US2020040381A1Selective oxidation of 5-methylcytosine by tet-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2019·Application pending·0 cites
- 3983US2022090176A1Methods of Epigenetic AnalysisCHILDRENS MEDICAL CT CORP·Filed 2021·Application pending·0 cites
- 4082US12569486B2Calmodulin inhibitors, CHK2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathiesCHILDRENS MEDICAL CT CORP·Filed 2024·Granted Mar 10, 2026·0 cites·6 claims
- 4182US2024117006A1Modified integrin polypeptides, modified integrin polypeptide dimers, and uses thereofCHILDRENS MEDICAL CT CORP·Filed 2023·Application pending·0 cites
- 4282US2025019407A1Pneumococcal fusion protein vaccinesCHILDRENS MEDICAL CT CORP·Filed 2024·Application pending·0 cites
- 4381US2021230679A1Methods of epigenetic analysisCHILDRENS MEDICAL CT CORP·Filed 2021·Application pending·0 cites
- 4481US2025333511A1Methods and compositions relating to anti-pd1 antibody reagentsCHILDRENS MEDICAL CT CORP·Filed 2025·Application pending·0 cites
- 4580US12467082B2Selective oxidation of 5-methylcytosine by tet-family proteinsCHILDRENS MEDICAL CT CORP·Filed 2025·Granted Nov 11, 2025·0 cites·25 claims
- 4680US12129283B2Pneumococcal fusion protein vaccinesCHILDRENS MEDICAL CT CORP·Filed 2022·Granted Oct 29, 2024·0 cites·21 claims
- 4780US11104713B2Modified integrin polypeptides, modified integrin polypeptide dimers, and uses thereofCHILDRENS MEDICAL CT CORP·Filed 2019·Granted Aug 31, 2021·1 cites·20 claims
- 4880US10668039B2Methods for treatment of adenoid cystic carcinomaCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Jun 2, 2020·2 cites·15 claims
- 4980US2023002733A1Cells with increased immuno-regulatory properties and methods for their use and manufactureCHILDRENS MEDICAL CT CORP·Filed 2022·Application pending·0 cites
- 5080US2023321150A1Pd-l1 expressing hematopoietic stem cells and usesCHILDRENS MEDICAL CT CORP·Filed 2023·Application pending·0 cites
Showing the top 50 of 257 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CHILDRENS MEDICAL CT CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →